H4ZB:F:F-HSBC FTSE 100 (EUR)

ETF | Others |

Last Closing

USD 86.98

Change

0.00 (0.00)%

Market Cap

USD 0.54B

Volume

37.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.27%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.11 (+0.22%)

USD 113.22B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.30 (-0.25%)

USD 83.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.13 (+0.25%)

USD 77.76B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.05 (+0.21%)

USD 73.13B
EUNL:F iShares Core MSCI World UCITS ..

-0.07 (-0.07%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.45 (-0.20%)

USD 56.29B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.04 (+0.28%)

USD 54.81B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.24 (-0.25%)

USD 51.63B

ETFs Containing H4ZB:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -2.05% 24% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.05% 22% F 42% F
Trailing 5 Years  
Capital Gain 1.51% 33% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.51% 33% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 3.05% 57% F 59% D-
Dividend Return 3.05% 55% F 54% F
Total Return N/A 99% N/A 100% F
Risk Return Profile  
Volatility (Standard Deviation) 14.37% 42% F 71% C-
Risk Adjusted Return 21.20% 50% F 55% F
Market Capitalization 0.54B 63% D 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.